Similar articles

• [A 100 years of aspirin: a drug with a future?].

  Sánchez García P. Sánchez García P. An R Acad Nac Med (Madr). 1997;114(1):157-63; discussion 164-7. An R Acad Nac Med (Madr). 1997. PMID: 9324911 Spanish. No abstract available.
• Efficacy and safety of aspirin in the long-term management of atherothrombosis.

  Patrono C. Patrono C. Haematologica. 2002 Jan;87(1):6-8. Haematologica. 2002. PMID: 11801459 No abstract available.
• [Aspirin in cardiovascular prevention: does the approach differ by gender?].

  Temizhan A. Temizhan A. Anadolu Kardiyol Derg. 2007 Dec;7 Suppl 2:2-4. Anadolu Kardiyol Derg. 2007. PMID: 18160359 Turkish.
• [Acetylsalicylic acid does not prevent cardiovascular disease. Poor scientific support for therapeutic guidelines according to primary prevention studies].

  Mooe T. Mooe T. Lakartidningen. 2006 Sep 20-26;103(38):2732-6. Lakartidningen. 2006. PMID: 17058766 Review. Swedish. No abstract available.
• Assessing the risk/benefit profile before recommending aspirin for the primary prevention of cardiovascular events.

  Rodondi N, Bauer DC. Rodondi N, et al. Am J Med. 2004 Oct 1;117(7):528-30. doi: 10.1016/j.amjmed.2004.07.037. Am J Med. 2004. PMID: 15464713 Review. No abstract available.